Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
Sponsor: Centre for Addiction and Mental Health
Summary
Within the schizophrenia population, there are individuals that respond to first-line antipsychotic treatments while others do not. The availability of muscarinic M4 subtype receptors (M4R) may play a role as to whether a person with schizophrenia is responsive to first-line antipsychotics or not. The goal of this observational study is to compare the availability of M4R in antipsychotic-free patients with schizophrenia and matched healthy controls. In addition, M4R availability in schizophrenia patients will be examined in relation to response to first line antipsychotics and clinical and cognitive measures. This study may help better understand antipsychotic resistance in schizophrenia and lead to the development of new treatment options, particularly for cognitive deficits and negative symptoms.
Official title: The Muscarinic Hypothesis of Schizophrenia: an [11C]MK-6884 PET Study Study Protocol
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
58
Start Date
2024-03-11
Completion Date
2026-03
Last Updated
2025-03-28
Healthy Volunteers
Yes
Conditions
Interventions
PET Scan
PET scan using the novel \[11C\]MK-6884 tracer to measure M4R during the antipsychotic-free state
Locations (1)
Centre for Addiction and Mental Health
Toronto, Ontario, Canada